Acute bacterial meningitis in adults

F McGill, RS Heyderman, S Panagiotou, AR Tunkel… - The Lancet, 2016 - thelancet.com
Over the past several decades, the incidence of bacterial meningitis in children has
decreased but there remains a significant burden of disease in adults, with a mortality of up …

Vaccines against meningococcal diseases

M Pizza, R Bekkat-Berkani, R Rappuoli - Microorganisms, 2020 - mdpi.com
Neisseria meningitidis is the main cause of meningitis and sepsis, potentially life-threatening
conditions. Thanks to advancements in vaccine development, vaccines are now available …

[HTML][HTML] Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020

SA Mbaeyi - MMWR. Recommendations and Reports, 2020 - cdc.gov
This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) for use of meningococcal vaccines in the United States …

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

R Borrow, P Alarcón, J Carlos, DA Caugant… - Expert review of …, 2017 - Taylor & Francis
ABSTRACT Introduction: The 2015 Global Meningococcal Initiative (GMI) meeting discussed
the global importance of meningococcal disease (MD) and its continually changing …

The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic …

R Acevedo, X Bai, R Borrow, DA Caugant… - Expert review of …, 2019 - Taylor & Francis
ABSTRACT Introduction: The 2018 Global Meningococcal Initiative (GMI) meeting focused
on evolving invasive meningococcal disease (IMD) epidemiology, surveillance, and …

Meningococcal B vaccine and meningococcal carriage in adolescents in Australia

HS Marshall, M McMillan, AP Koehler… - … England Journal of …, 2020 - Mass Medical Soc
Background The meningococcal group B vaccine 4CMenB is a new, recombinant protein-
based vaccine that is licensed to protect against invasive group B meningococcal disease …

[HTML][HTML] Use of serogroup B meningococcal vaccines in persons aged≥ 10 years at increased risk for serogroup B meningococcal disease: recommendations of the …

T Folaranmi, L Rubin, SW Martin, M Patel… - … and Mortality Weekly …, 2015 - ncbi.nlm.nih.gov
Methods The ACIP Meningococcal Vaccines Work Group reviewed safety and
immunogenicity data from seven clinical trials of MenB-4C (2–7)(Novartis, unpublished data) …

Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015

JR MacNeil, L Rubin, T Folaranmi… - Morbidity and Mortality …, 2015 - JSTOR
Methods The ACIP Meningococcal Vaccines Work Group reviewed the immunogenicity and
safety data from seven clinical trials of MenB-FHbp (2–5)(Pfizer, unpublished data) and five …

The development of a vaccine against meningococcus B using reverse vaccinology

V Masignani, M Pizza, ER Moxon - Frontiers in immunology, 2019 - frontiersin.org
The discovery of vaccine antigens through whole genome sequencing (WGS) contrasts with
the classical hypothesis-driven laboratory-based analysis of microbes to identify …

Neurologic manifestations of the World Health Organization's list of pandemic and epidemic diseases

CRS McEntire, KW Song, RP McInnis, JY Rhee… - Frontiers in …, 2021 - frontiersin.org
The World Health Organization (WHO) monitors the spread of diseases globally and
maintains a list of diseases with epidemic or pandemic potential. Currently listed diseases …